Cargando…
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
BACKGROUND: This study examines venous thromboembolism (VTE)-associated resource utilization and real-world costs in ambulatory patients initiating chemotherapy for selected common high-risk solid tumors. METHODS: Health care claims data (2004–2009) from the IMS/PharMetrics(®) Patient-Centric databa...
Autores principales: | Khorana, Alok A, Dalal, Mehul R, Lin, Jay, Connolly, Gregory C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575127/ https://www.ncbi.nlm.nih.gov/pubmed/23430767 http://dx.doi.org/10.2147/CEOR.S39964 |
Ejemplares similares
-
Prevention of venous thromboembolism in ambulatory patients with cancer
por: Khorana, Alok A, et al.
Publicado: (2020) -
Evolving Treatment Options for Cancer-Related Venous Thromboembolism
por: Attia, Doaa, et al.
Publicado: (2020) -
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
por: Bauersachs, Rupert, et al.
Publicado: (2020) -
Guidance for the prevention and treatment of cancer-associated venous thromboembolism
por: Khorana, Alok A., et al.
Publicado: (2016) -
RNA expression and risk of venous thromboembolism in lung cancer
por: Sussman, Tamara A., et al.
Publicado: (2019)